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ETEC related post-weaning diarrhea causes recurrent economic losses to the porcine rearing 
industry. The embargo on antibiotic prophylaxis has led to a pressing need for a suitable 
alternative. To evaluate feed based oral prophylactic passive immunization against ETEC, we 
produced antibodies in seeds of Arabidopsis thaliana. Antibodies were designed by grafting 4 
variable domains of lama heavy chain 11 antibodies (VHH) against ETEC on the Fc part of 
porcine IgG and IgA. Transformants producing the 4 VHH-IgG and 4 VHH-IgA antibodies 
from 0.2% up to 3% of seed weight were obtained. Cotransformation of the VHH-IgA 
constructs with porcine joining chain and secretory component led to production of assembled 
dimeric and secretory IgA like antibodies in seeds. In vitro analysis of the antibody producing 
seed extracts were all effective in aggregating ETEC and inhibiting bacterial binding to 
porcine gut villous enterocytes. In a piglet feed-challenge experiment, the feed containing a 
milled cocktail of all the VHH-IgA based antibodies (dose 20mg/ pig/ day) protected the 
piglets against the challenge infection; while feed with the 4 VHH-IgG producing seeds (dose 
80mg/ pig/ day) failed to offer similar protection. Piglets receiving the VHH-IgA antibodies had 
a swift decline in shedding of ETEC, the seroconversion was significantly lower and they had 
a higher weight gain. Thus these results show a feasibility proof for oral passive immunization 
against ETEC. 
